We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-15.19%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.4B
AUM Growth
-$2.53B
(-20%)
Cap. Flow
-$239M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
18.85%
Holding
2,568
New
165
Increased
997
Reduced
1,065
Closed
296
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$80.7M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$47.3M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$44.7M |
| 4 |
Vanguard Total Bond Market
BND
|
+$37M |
| 5 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$27.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$94M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$30.1M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$28.6M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$20.1M |
| 5 |
iShares Core S&P US Growth ETF
IUSG
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.95% |
| 2 | Healthcare | 4.79% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Communication Services | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Corbus Pharmaceuticals
CRBP
$196M
| $252K | ﹤0.01% |
1,603
-22
| -1% | -$3.72K |
|
1777
Editas Medicine
EDIT
$432M
| $252K | ﹤0.01% |
12,720
+5,012
| +65% | +$126K |
|
1778
Ferrari
RACE
$72.5B
| $252K | ﹤0.01% |
1,643
-757
| -32% | -$122K |
|
1779
Whirlpool
WHR
$2.8B
| $252K | ﹤0.01% |
2,937
-1,194
| -29% | -$157K |
|
|
IGD
1780
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$525M
| $251K | ﹤0.01% |
55,129
-22,671
| -29% | -$129K |
|
1781
Cass Information Systems
CASS
$750M
| $250K | ﹤0.01% |
7,101
-12,064
| -63% | -$583K |
|
1782
CRISPR Therapeutics
CRSP
$5.24B
| $250K | ﹤0.01% |
5,903
-995
| -14% | -$51.4K |
|
|
GHY
1783
PGIM Global High Yield Fund
GHY
$480M
| $250K | ﹤0.01% |
22,632
-6,483
| -22% | -$90.6K |
|
1784
Credit Acceptance
CACC
$6.06B
| $249K | ﹤0.01% |
974
-29
| -3% | -$11.7K |
|
|
CTLT
1785
DELISTED
CATALENT, INC.
CTLT
| $249K | ﹤0.01% |
+4,797
| New | +$262K |
|
|
RESP
1786
DELISTED
WisdomTree U.S. ESG Fund
RESP
| $249K | ﹤0.01% |
9,085
-150
| -2% | -$5.09K |
|
1787
Box
BOX
$4.67B
| $248K | ﹤0.01% |
17,697
+3,495
| +25% | +$52K |
|
|
MNDT
1788
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $248K | ﹤0.01% |
23,407
+146
| +0.6% | +$2.1K |
|
1789
Allegion
ALLE
$14.2B
| $247K | ﹤0.01% |
2,682
-210
| -7% | -$25.1K |
|
|
NCZ
1790
Virtus Convertible & Income Fund II
NCZ
$305M
| $247K | ﹤0.01% |
18,518
+1,798
| +11% | +$33.2K |
|
1791
PIMCO Broad US TIPS Index Exchange-Traded Fund
TIPZ
$88.5M
| $247K | ﹤0.01% |
4,064
+26
| +0.6% | +$1.57K |
|
1792
WisdomTree Managed Futures Strategy Fund
WTMF
$250M
| $247K | ﹤0.01% |
6,818
-475
| -7% | -$17.2K |
|
|
TRTN
1793
DELISTED
Triton International Limited
TRTN
| $247K | ﹤0.01% |
9,555
-872
| -8% | -$29.8K |
|
1794
International Flavors & Fragrances
IFF
$21.4B
| $246K | ﹤0.01% |
2,411
+567
| +31% | +$70.6K |
|
1795
Virgin Galactic
SPCE
$474M
| $246K | ﹤0.01% |
+834
| New | +$317K |
|
1796
DigitalBridge
DBRG
$2.94B
| $245K | ﹤0.01% |
34,983
+6,107
| +21% | +$96.9K |
|
1797
Hexcel
HXL
$7.73B
| $245K | ﹤0.01% |
6,578
-1,963
| -23% | -$127K |
|
1798
National Fuel Gas
NFG
$7.75B
| $245K | ﹤0.01% |
6,571
-3,499
| -35% | -$143K |
|
1799
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.57B
| $244K | ﹤0.01% |
12,376
+1,041
| +9% | +$21.3K |
|
|
CMU
1800
DELISTED
MFS High Yield Municipal Trust
CMU
| $244K | ﹤0.01% |
57,737
+1,437
| +3% | +$6.65K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Cambridge Investment Research Advisors held 2,568 positions worth $10.4B, down 20% from $13B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors's Q1 2020 filing shows 165 new, 997 increased, 1,065 reduced and 296 closed positions. Its largest new stake was iShares GNMA Bond ETF: 171,895 shares worth $8.87M. The largest sale was Vanguard S&P 500 ETF, an estimated $94M.
By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 6.9% a quarter earlier, followed by Healthcare and Financials.
- Cambridge Investment Research Advisors's largest Q1 2020 buy was iShares GNMA Bond ETF: 171,895 shares worth $8.87M.
- Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q1 2020, an estimated $80.7M increase.
- Cambridge Investment Research Advisors's biggest Q1 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $94M.
- Cambridge Investment Research Advisors fully exited Schwab Fundamental International Small Company Index ETF in Q1 2020, selling an estimated $10.9M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $10.4B portfolio in Q1 2020.
- Cambridge Investment Research Advisors opened 165 new positions and closed 296 in Q1 2020.
- Cambridge Investment Research Advisors's portfolio value fell 20% quarter-over-quarter to $10.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2020, filed 8 May 2020.